Epidiolex Receives Initial Recommendation from FDA Committee

Epidiolex, a CBD-based pharmaceutical medication created by GW Pharmaceuticals in the United Kingdom, has received a recommendation from an FDA advisory committee. The committee's recommendation was unanimous and sets Epidiolex up to potentially receive FDA approval for U.S. ...

read more here
Delivered by @can_nab_is